• What we do
  • Portfolio
  • Team
  • News

Hercules Pharmaceuticals B.V

Published on: 6 August 2020

Hercules is a biopharmaceutical company developing an innovative, oral, non-toxic drug therapy for chronic treatment of patients with Triple Negative Breast Cancer, and other solid tumors.

← Philae Pharmaceuticals

Recent Posts

  • Griphingo and partners receive investment for innovative inhalation therapy
  • Pharma Connect Capital invests in Hercules Pharmaceuticals B.V.
  • Symposium Translating Science into Innovative Treatment
  • Pharma Connect Capital invests in Philae Pharmaceuticals
  • February 2019: Pharma Connect Capital invests in BiOrion.

About Us

Pharma Connect Capital participates in startup companies located in Groningen, Friesland & Drenthe with a mission to develop new drugs, drug delivery technologies, biomarkers or diagnostics.

Navigate

  • Contact
  • News
  • Team
  • Portfolio

Contact Us

L.J. Zielstraweg 2
9713 GX Groningen

Phone: +31 (0)6 53 72 60 22
Email: info@pharmaconnectcapital.com

© PharmaConnectCapital 2016 - 2022 - Webdesign & Development by Skitter